Cargando…

Immunosuppressive Treatment for Nephrotic Idiopathic Membranous Nephropathy: A Meta-Analysis Based on Chinese Adults

BACKGROUND: Idiopathic membranous nephropathy (IMN) is the most common pathological type for nephrotic syndrome in adults in western countries and China. The benefits and harms of immunosuppressive treatment in IMN remain controversial. OBJECTIVES: To assess the efficacy and safety of different immu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Guoqiang, Xu, Jing, Ye, Chaoyang, Chen, Dongping, Xu, Chenggang, Yang, Li, Ma, Yiyi, Hu, Xiaohong, Li, Lin, Sun, Lijun, Zhao, Xuezhi, Mao, Zhiguo, Mei, Changlin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434188/ https://www.ncbi.nlm.nih.gov/pubmed/22957065 http://dx.doi.org/10.1371/journal.pone.0044330

Ejemplares similares

Cyclosporine A for the treatment of refractory nephrotic syndrome with renal dysfunction
por: GAO, XIANG, et al.
Publicado: (2014)

Acute kidney injury in idiopathic membranous nephropathy with nephrotic syndrome
por: Chen, Tianxin, et al.
Publicado: (2021)

Different Effects of Tolvaptan in Patients with Idiopathic Membranous Nephropathy with Nephrotic Syndrome
por: Tanaka, Atsushi, et al.
Publicado: (2017)

Electron-Dense Deposition Patterns and the Outcomes of Nephrotic Idiopathic Membranous Nephropathy Treated with Tacrolimus in Chinese Adults
por: Xiang, Xin, et al.
Publicado: (2021)

Antihypertensive treatments in adult autosomal dominant polycystic kidney disease: network meta-analysis of the randomized controlled trials
por: Xue, Cheng, et al.
Publicado: (2015)

Comparative efficacy of 13 immunosuppressive agents for idiopathic membranous nephropathy in adults with nephrotic syndrome: a systematic review and network meta-analysis
por: Zheng, Qiyan, et al.
Publicado: (2019)

Herbal Medicine “Shulifenxiao” Formula for Nephrotic Syndrome of Refractory Idiopathic Membranous Nephropathy
por: Cui, Hailan, et al.
Publicado: (2021)

Chinese medicinal herbs for idiopathic membranous nephropathy in adults with nephrotic syndrome: A systematic review of effectiveness and safety
por: Liu, Meifang, et al.
Publicado: (2021)

Complete staghorn calculus in polycystic kidney disease: infection is still the cause
por: Mao, Zhiguo, et al.
Publicado: (2013)

The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy
por: Liang, Qian, et al.
Publicado: (2017)

Immunosuppressive therapy for progressive idiopathic membranous nephropathy: a cost-effectiveness analysis in China
por: Xu, Wanyi, et al.
Publicado: (2023)

Nephrotic Syndrome and Idiopathic Membranous Nephropathy Associated with Autosomal-Dominant Polycystic Kidney Disease
por: Peces, Ramón, et al.
Publicado: (2011)

Immunosuppressive treatment for idiopathic membranous nephropathy: An updated network meta-analysis
por: Bao, Neng, et al.
Publicado: (2023)

Efficacy and safety of 12 immunosuppressive agents for idiopathic membranous nephropathy in adults: A pairwise and network meta-analysis
por: Liu, Jiarong, et al.
Publicado: (2022)

Immunosuppression therapy for idiopathic membranous nephropathy: systematic review with network meta-analysis
por: Bose, Bhadran, et al.
Publicado: (2022)

Clinical Characteristics and Disease Predictors of a Large Chinese Cohort of Patients with Autosomal Dominant Polycystic Kidney Disease
por: Chen, Dongping, et al.
Publicado: (2014)

Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis
por: Ren, Song, et al.
Publicado: (2017)

Nomogram to predict the progression of patients with primary membranous nephropathy and nephrotic syndrome
por: Liu, Lili, et al.
Publicado: (2021)

Primary IgA nephropathy with nephrotic-range proteinuria in Chinese children
por: Zhao, Jing-Li, et al.
Publicado: (2021)

Spironolactone Plus Full-Dose ACE Inhibition in Patients with Idiopathic Membranous Nephropathy and Nephrotic Syndrome: Does It Really Work?
por: Cravedi, Paolo, et al.
Publicado: (2010)

Fractional excretion of IgG in idiopathic membranous nephropathy with nephrotic syndrome: a predictive marker of risk and drug responsiveness
por: Bazzi, Claudio, et al.
Publicado: (2014)

Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome
por: Saito, Takao, et al.
Publicado: (2016)

Comparison of prognostic, clinical, and renal histopathological characteristics of overlapping idiopathic membranous nephropathy and IgA nephropathy versus idiopathic membranous nephropathy
por: Chen, Xinxin, et al.
Publicado: (2017)

Helper T Cells in Idiopathic Membranous Nephropathy
por: Zhao, Qihan, et al.
Publicado: (2021)

Glomerulosclerosis is a prognostic risk factor in patients with membranous nephropathy and non-nephrotic proteinuria
por: Sun, Jing, et al.
Publicado: (2023)

Complete remission of nephrotic syndrome in a young woman with anti-LRP2 nephropathy after immunosuppressive therapy
por: Zhu, Xiaoye, et al.
Publicado: (2020)

Low-dose cyclosporine in treatment of membranous nephropathy with nephrotic syndrome: effectiveness and renal safety
por: Yu, Xiaojuan, et al.
Publicado: (2017)

Non-diabetic urine glucose in idiopathic membranous nephropathy
por: Liu, Lingling, et al.
Publicado: (2022)

Research Progress in the Treatment of Idiopathic Membranous Nephropathy using Traditional Chinese Medicine
por: Lang, Rui, et al.
Publicado: (2020)

Chapter 7: Idiopathic membranous nephropathy
Publicado: (2012)

Treatment with rituximab in idiopathic membranous nephropathy
por: Fiorentino, Marco, et al.
Publicado: (2016)

Risk alleles for IgA nephropathy-associated SNPs conferred completely opposite effects to idiopathic membranous nephropathy in Chinese Han
por: Qin, Xiaosong, et al.
Publicado: (2017)

Association of gut microbiota with idiopathic membranous nephropathy
por: Li, Mengfei, et al.
Publicado: (2022)

Biomarkers to detect membranous nephropathy in Chinese patients
por: Lin, Li, et al.
Publicado: (2016)

The non-immunosuppressive management of childhood nephrotic syndrome
por: McCaffrey, James, et al.
Publicado: (2015)

Real-World Effects of Chinese Herbal Medicine for Idiopathic Membranous Nephropathy (REACH-MN): Protocol of a Registry-Based Cohort Study
por: Yang, Lihong, et al.
Publicado: (2022)

Advances of the experimental models of idiopathic membranous nephropathy
por: Jiang, Han Xue, et al.
Publicado: (2020)

A pilot study to determine the dose and effectiveness of adrenocorticotrophic hormone (H.P. Acthar® Gel) in nephrotic syndrome due to idiopathic membranous nephropathy
por: Hladunewich, Michelle A., et al.
Publicado: (2014)

Association between PLA2R gene polymorphism and idiopathic membranous nephropathy in Heilongjiang Chinese
por: Tian, Tian, et al.
Publicado: (2023)

Effectiveness and safety of cyclophosphamide or tacrolimus therapy for idiopathic membranous nephropathy
por: Zou, Honghong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_di71u3ie5m6f798e07i7ubfpnu